Q1WB
UTHR icon

Quest 10 Wealth Builders’s United Therapeutics UTHR Stock Holding History

Quest 10 Wealth Builders’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15
Closed -$8.89K – 823
2026
Q1 		$8.89K Buy
+15
New +$7.47K 0.01% 458
2025
Q4 		– Sell
-20
Closed -$8.38K – 899
2025
Q3 		$8.38K Buy
+20
New +$6.73K 0.01% 402

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Quest 10 Wealth Builders's UTHR Position: Q2 2026 in Review

Quest 10 Wealth Builders sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 15 shares — an estimated $8.89K sold.

Quest 10 Wealth Builders first reported a position in UTHR in Q3 2025 and held it in 2 quarters. The position peaked at $8.89K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Quest 10 Wealth Builders reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quest 10 Wealth Builders sold 15 United Therapeutics shares in Q2 2026, an estimated $8.89K.
  • Quest 10 Wealth Builders first reported a position in United Therapeutics in Q3 2025 and held it in 2 quarters.
  • Quest 10 Wealth Builders's United Therapeutics position peaked at $8.89K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.